Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
7.33 USD | -0.14% | -1.35% | +95.99% |
Mar. 21 | Fate Therapeutics, Inc. announced that it has received $19.996366 million in funding from Redmile Group, LLC | CI |
Mar. 19 | Fate Therapeutics Prices $100 Million Offering, Private Placement | MT |
- Stock
- Equities
- Stock Fate Therapeutics, Inc. - Nasdaq
- News Fate Therapeutics, Inc.